[Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
Gabriella Lengyel, Rózsa Fehér, S Gardó, János Fehér
Abstract
Gabriella Lengyel, Rózsa Fehér, S Gardó, János Fehér
Abstract
INTRODUCTION: Intrahepatic cholestasis of pregnancy is a rare disorder of unknown origin with a symptomatically distressing maternal course with pruritus and icterus as the chief complaints. The disease poses little medical risk to the mother, but poses significantly risk to the fetus of perinatal mortality, preterm delivery, fetal distress, and meconium staining. Beside the pruritus and the high level of bilirubin in the serum the increased values of parameters showing the liver function and of alkaline phosphatase activity are characteristic. Ursodeoxycholic acid is the only therapeutic modality whose effectiveness was proven by controlled trial. CASE REPORT: The authors demonstrate the case of a 29 year old woman who developed intrahepatic cholestasis with the characteristic clinical and laboratory findings at the 33rd week of her pregnancy. The clinical complains disappeared and the liver function tests were better after the applied ursodeoxycholic acid treatment. The delivery was carried out without complications with a healthy newborn baby. DISCUSSION AND CONCLUSION: On the basis of the data in the literature and of this case report the authors recommend the ursodeoxycholic acid treatment in the management of intrahepatic cholestasis of pregnancy.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
INTRODUCTION: Intrahepatic cholestasis of pregnancy is a rare disorder of unknown origin with a symptomatically distressing maternal course with pruritus and icterus as the chief complaints. The disease poses little medical risk to the mother, but poses significantly risk to the fetus of perinatal mortality, preterm delivery, fetal distress, and meconium staining. Beside the pruritus and the high level of bilirubin in the serum the increased values of parameters showing the liver function and of alkaline phosphatase activity are characteristic. Ursodeoxycholic acid is the only therapeutic modality whose effectiveness was proven by controlled trial. CASE REPORT: The authors demonstrate the case of a 29 year old woman who developed intrahepatic cholestasis with the characteristic clinical and laboratory findings at the 33rd week of her pregnancy. The clinical complains disappeared and the liver function tests were better after the applied ursodeoxycholic acid treatment. The delivery was carried out without complications with a healthy newborn baby. DISCUSSION AND CONCLUSION: On the basis of the data in the literature and of this case report the authors recommend the ursodeoxycholic acid treatment in the management of intrahepatic cholestasis of pregnancy.
Key concepts: Ursodeoxycholic acid, Cholestasis of pregnancy, Medicine, Cholestasis, Pregnancy, Bile acid, Gastroenterology, Fetal distress